Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00177
|
|||||
Drug Name |
Cetirizine
|
|||||
Synonyms |
(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid; (2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-acetic acid; (2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid; 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid; Cetiderm; Cetiderm (TN); Cetirizin; Cetirizina; Cetirizina [Spanish]; Cetirizine (INN); Cetirizine [INN:BAN]; Cetirizinum; Cetirizinum [Latin]; Cetrizine Hcl; Cetryn; Hitrizin Film Tablet; P-071; Reactine (TN); Setir; Virlix; Ziptek; Zirtek; Zyrlex; Zyrtec (TN); [(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]acetic acid
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Allergic rhinitis [ICD11:CA08.0] | Approved | [1] | |||
Therapeutic Class |
Antiallergic Agents
|
|||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C21H25ClN2O3
|
|||||
Canonical SMILES |
C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
|
|||||
InChI |
InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)
|
|||||
InChIKey |
ZKLPARSLTMPFCP-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 83881-51-0
|
|||||
Pharmaceutical Properties | Molecular Weight | 388.9 | Topological Polar Surface Area | 53 | ||
Heavy Atom Count | 27 | Rotatable Bond Count | 8 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | |||
XLogP |
1.7
|
|||||
PubChem CID | ||||||
PubChem SID |
103266652
,104170194
,104301286
,108136263
,11466531
,11467651
,11486082
,11501857
,117611598
,117843325
,121362416
,124526347
,125324646
,125339821
,125544920
,125822846
,126525325
,126582564
,126619301
,14756386
,29221835
,46508368
,47359454
,47583265
,47953980
,48179259
,48403972
,48415747
,49698526
,49846704
,49861380
,50112918
,50112919
,50112920
,50276923
,51091966
,5658851
,57321395
,57581408
,7978899
,81041207
,8151737
,85209379
,853774
,85788875
,90341832
,92290962
,92721266
,93624540
,9980
|
|||||
ChEBI ID |
ChEBI:3561
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Cetirizine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction. Chirality. 2010 Jul;22(7):684-92. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.